PNC Financial Services Group’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,418	Closed	-$1.66K	–	4885
2024 Q2	$1.66K	Buy	+1,418	New	+$1.66K	﹤0.01%	4301
2024 Q1	–	Sell	-19	Closed	-$34	–	4789
2023 Q4	$34	Buy	+19	New	+$34	﹤0.01%	4585